Surgical Management of Acute Type A Aortic Dissection
- 1Department of Cardiothoracic Surgery, Northwell Cardiovascular Institute, Manhasset, NY 11030, USA
- 2Division of Cardiac Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
Abstract
Acute type A aortic dissection (ATAAD) is a life-threatening cardiovascular emergency characterized by disruption of the ascending aortic intima with subsequent propagation of a false lumen. Population-based studies report an annual incidence of approximately 3 cases per 100,000 patient-years. Despite advances in diagnosis and surgical management, 30-day operative mortality remains approximately 10–20%, with higher rates in the presence of malperfusion syndrome, cardiac tamponade, or aortic rupture. This narrative review summarizes the current understanding of ATAAD pathophysiology, classification systems, diagnostic modalities, and evolving management strategies, with particular emphasis on contemporary surgical techniques and organ protection strategies employed during repair. Hypertension remains the most significant modifiable risk factor for ATAAD, whereas hereditary thoracic aortic disease (HTAD) predisposes younger patients to dissection. The Penn classification stratifies mortality risk according to the pattern of malperfusion; coronary and mesenteric malperfusion are associated with the highest mortality. Surgical management has evolved from traditional hemiarch replacement to more extensive arch replacement, with or without frozen elephant trunk (FET) techniques, and emerging data demonstrate improved long-term durability. Moderate hypothermic circulatory arrest (MHCA) with antegrade cerebral perfusion (ACP) has emerged as the preferred neuroprotective strategy, offering outcomes comparable to those achieved with deep hypothermic circulatory arrest (DHCA) alone. Treatment at high-volume comprehensive aortic centers is associated with improved survival. Management of ATAAD continues to evolve through ongoing refinements in surgical techniques, organ-protection strategies, and perioperative care. While prompt surgical intervention remains the cornerstone of treatment, individualized management that incorporates patient-specific anatomy, malperfusion patterns, and institutional expertise is essential. Long-term surveillance and follow-up at specialized aortic centers are critical for detecting and managing late complications, and genetic evaluation is recommended to identify HTAD in appropriate patients.
Related
- Perioperative management of acute type A aortic dissection using extended half-life factor IX (Alprolix) in a patient with severe hemophilia B: a case report.
- Perioperative prothrombin time activity trajectories and subsequent mortality after surgical repair of acute type A aortic dissection
- Hybrid approach with thoracic endovascular treatment and abdominal aortic replacement for acute type B aortic dissection complicated by ruptured abdominal aortic aneurysm
- Sequential Arch-Tear Eligibility for Uncovered Aortic Arch Stent in Acute DeBakey Type I Aortic Dissection
- Digital Twin-Based Risk Stratification Integrating Aortic Shape and Wall Mechanics in Acute Uncomplicated Type B Aortic Dissection
BibTeX
@article{kiridly2026surgical,
title = {{Surgical Management of Acute Type A Aortic Dissection}},
author = {Adam H Kiridly and Michael A Catalano and Branden Tejada and Michele Dell’Aquila and Isabella Kola and Omar A Jarral and Stevan S Pupovac and Derek R Brinster},
journal = {Reviews in Cardiovascular Medicine},
year = {2026},
month = oct,
doi = {10.31083/rcm54094},
url = {https://doi.org/10.31083/rcm54094},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Surgical Management of Acute Type A Aortic Dissection
AU - Adam H Kiridly
AU - Michael A Catalano
AU - Branden Tejada
AU - Michele Dell’Aquila
AU - Isabella Kola
AU - Omar A Jarral
AU - Stevan S Pupovac
AU - Derek R Brinster
PY - 2026
DA - 2026/10/13
JO - Reviews in Cardiovascular Medicine
DO - 10.31083/rcm54094
UR - https://doi.org/10.31083/rcm54094
AB - Acute type A aortic dissection (ATAAD) is a life-threatening cardiovascular emergency characterized by disruption of the ascending aortic intima with subsequent propagation of a false lumen. Population-based studies report an annual incidence of approximately 3 cases per 100,000 patient-years. Despite advances in diagnosis and surgical management, 30-day operative mortality remains approximately 10–20%, with higher rates in the presence of malperfusion syndrome, cardiac tamponade, or aortic rupture. This narrative review summarizes the current understanding of ATAAD pathophysiology, classification systems, diagnostic modalities, and evolving management strategies, with particular emphasis on contemporary surgical techniques and organ protection strategies employed during repair. Hypertension remains the most significant modifiable risk factor for ATAAD, whereas hereditary thoracic aortic disease (HTAD) predisposes younger patients to dissection. The Penn classification stratifies mortality risk according to the pattern of malperfusion; coronary and mesenteric malperfusion are associated with the highest mortality. Surgical management has evolved from traditional hemiarch replacement to more extensive arch replacement, with or without frozen elephant trunk (FET) techniques, and emerging data demonstrate improved long-term durability. Moderate hypothermic circulatory arrest (MHCA) with antegrade cerebral perfusion (ACP) has emerged as the preferred neuroprotective strategy, offering outcomes comparable to those achieved with deep hypothermic circulatory arrest (DHCA) alone. Treatment at high-volume comprehensive aortic centers is associated with improved survival. Management of ATAAD continues to evolve through ongoing refinements in surgical techniques, organ-protection strategies, and perioperative care. While prompt surgical intervention remains the cornerstone of treatment, individualized management that incorporates patient-specific anatomy, malperfusion patterns, and institutional expertise is essential. Long-term surveillance and follow-up at specialized aortic centers are critical for detecting and managing late complications, and genetic evaluation is recommended to identify HTAD in appropriate patients.
SN - 1530-6550
SN - 2153-8174
ER -